Dishman Carbogen Amcis Powers Ahead: Shanghai Site Earns NMPA Drug Manufacturing License

Unknown Apr 02, 2026 350 Views

Dishman Carbogen Amcis Ltd. announced a major breakthrough as its fully owned subsidiary, CARBOGEN AMCIS (Shanghai) Co. Ltd., has been granted a Drug Manufacturing License by the National Medical Products Administration (NMPA) of China. The April 8, 2025, dated license allows the company to start...

Stay Ahead – Explore Now! RBI Sets Underwriting Commitment for New Government Bond Auction